摘要
抗体靶向型细胞质的药物是难以实现抗原抗体相互作用,导致负载被定向到小隔间。然而,由于F-protein介导膜融合,仙台病毒包膜会引起细胞质传递。本研究中我们已经生成并融合重组scFv定向到肿瘤-胎儿抗原,是一种具有膜转运和仙台F蛋白的部分胞质域的胎盘碱性磷酸酶同工酶(PAP)。重组病毒颗粒,同时拥有融合蛋白以及主体F-蛋白,能够具体绑定和释放药物至PAP表达细胞。大约75%的递质是胞质。因此,这免疫病毒颗粒缺乏相对毒性更大的HN蛋白,能够结合具体抗体介导的胞质递质。scFv能特异性结合PAP表达细胞,没有与其他碱性磷酸酶同功酶的交叉反应。胞质传递的优势包括减少低负载和载体的免疫原性的退化和削弱。PAP在各种癌症如精原细胞瘤、绒毛膜癌,宫颈癌和乳腺癌等中的表达普遍存在,也表明其在众多恶性肿瘤治疗中的潜在作用。
关键词: F-蛋白,F-病毒颗粒,胎盘碱性磷酸酶,单链抗体可变区基因片段,仙台病毒,靶向给药
Current Molecular Medicine
Title:Membrane Fusion Mediated Targeted Cytosolic Drug Delivery Through scFv Engineered Sendai Viral Envelopes
Volume: 15 Issue: 4
Author(s): M. Kumar, P. Mani, P. Pratheesh, S. Chandra, M. Jeyakkodi, P. Chattopadhyay, D.P. Sarkar and S. Sinha
Affiliation:
关键词: F-蛋白,F-病毒颗粒,胎盘碱性磷酸酶,单链抗体可变区基因片段,仙台病毒,靶向给药
摘要: Antibody targeted cytoplasmic delivery of drugs is difficult to achieve as antigen-antibody interaction results in the payload being directed to the endosomal compartment. However, Sendai viral envelopes can bring about cytoplasmic delivery due to F-protein mediated membrane fusion. In this study we have generated and fused a recombinant scFv directed to the onco-fetal antigen, the Placental isozyme of Alkaline Phosphatase (PAP) with the trans-membrane and part of the cytoplasmic domain of the Sendai F protein (FTMC). Reconstituted virosomes, having both the fusion protein as well as the native F-protein were able to specifically bind and deliver drugs to PAP expressing cells. About 75% of the delivery was cytoplasmic in nature. Hence, this immuno-virosome, which is devoid of the comparatively more toxic HN protein, has the novel ability to combine specific antibody mediated targeting with cytoplasmic delivery. The scFv ensured specific binding to PAP expressing cells, without cross reacting with the other isozymes of alkaline phosphatase. The advantages of cytoplasmic delivery would include reduced degradation and lowered immunogenicity of the payload and carrier. The ubiquitous expression of PAP on a variety of cancers like seminoma, choriocarcinoma, cervical and breast cancers also suggests its potential usefulness in a number of malignancies.
Export Options
About this article
Cite this article as:
M. Kumar, P. Mani, P. Pratheesh, S. Chandra, M. Jeyakkodi, P. Chattopadhyay, D.P. Sarkar and S. Sinha , Membrane Fusion Mediated Targeted Cytosolic Drug Delivery Through scFv Engineered Sendai Viral Envelopes, Current Molecular Medicine 2015; 15 (4) . https://dx.doi.org/10.2174/1566524015666150505155949
DOI https://dx.doi.org/10.2174/1566524015666150505155949 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Membrane and Soluble Forms of Endoglin in Preeclampsia
Current Molecular Medicine Cellular Relationships of Testicular Germ Cell Tumors Determined by Partial Canonical Correlation Analysis of Gene Expression Signatures
Current Bioinformatics Killing Glioma ‘Stem-like’ Cells via Drug-Induced Relocation of Endosomal Urokinase Proteins
Anti-Cancer Agents in Medicinal Chemistry Sex Hormones and their Analogues in Neuroimmune Biology
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Metabolic Functions of Myostatin and GDF11
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Search for New and Novel Chemotherapeutics for the Treatment of Human Malignancies
Mini-Reviews in Medicinal Chemistry Reconstituted High Density Lipoprotein-Based Nanoparticles: an Overview of Applications in Regenerative Medicine, Preparation, Evaluation and Future Trends
Current Pharmaceutical Design The Renin-angiotensin System as a Target of Novel Anticancer Therapy
Current Pharmaceutical Design New Perspectives in Glioma Immunotherapy
Current Pharmaceutical Design Emulsomes Meet S-layer Proteins: An Emerging Targeted Drug Delivery System
Current Pharmaceutical Biotechnology New Anti-Cancer Strategies in Testicular Germ Cell Tumors
Recent Patents on Anti-Cancer Drug Discovery Inhibition of Apoptosis in Pediatric Cancer by Survivin
Current Pediatric Reviews Melatonin in Pregnancy: Effects on Brain Development and CNS Programming Disorders
Current Pharmaceutical Design Serotonin as a Modulator of Immune Function: An Overview
Current Immunology Reviews (Discontinued) HLA-G Expression in Cancers: Potential Role in Diagnosis, Prognosis and Therapy
Endocrine, Metabolic & Immune Disorders - Drug Targets Vertebrate Protein CTCF and its Multiple Roles in a Large-Scale Regulation of Genome Activity
Current Genomics Management of Ovarian Cancer In Younger Women
Reviews on Recent Clinical Trials The Urokinase Plasminogen Activator System: A Target for Anti-Cancer Therapy
Current Cancer Drug Targets Epigenetic Regulation of Cytochrome P450 Enzymes and Clinical Implication
Current Drug Metabolism Dysregulation of LncRNAs in Placenta and Pathogenesis of Preeclampsia
Current Drug Targets